SI-BONE Receives 510(k) Clearance And FDA Breakthrough Device Designation For iFuse TORQ TNT Implant System
Portfolio Pulse from Benzinga Newsdesk
SI-BONE has received 510(k) clearance and FDA Breakthrough Device Designation for its iFuse TORQ TNT Implant System, potentially enhancing its market position and product offerings.
August 20, 2024 | 12:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
SI-BONE has achieved significant regulatory milestones with the 510(k) clearance and FDA Breakthrough Device Designation for its iFuse TORQ TNT Implant System. This could enhance its competitive edge and market reach.
The 510(k) clearance allows SI-BONE to market the iFuse TORQ TNT Implant System, while the FDA Breakthrough Device Designation highlights its innovative potential. These regulatory achievements can lead to increased adoption and sales, positively impacting the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100